CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 35 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,000 | -37.5% | 21,012 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | -42.9% | 21,012 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -17.6% | 21,012 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | -29.2% | 21,012 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | -55.6% | 21,012 | -0.9% | 0.00% | – |
| Q3 2021 | $54,000 | +1.9% | 21,212 | +17.8% | 0.00% | – |
| Q2 2021 | $53,000 | -15.9% | 18,000 | 0.0% | 0.00% | – |
| Q1 2021 | $63,000 | -75.3% | 18,000 | -66.4% | 0.00% | -100.0% |
| Q4 2020 | $255,000 | +16.4% | 53,541 | +18.2% | 0.00% | 0.0% |
| Q3 2020 | $219,000 | +48.0% | 45,278 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $148,000 | -14.5% | 45,278 | +33.9% | 0.00% | 0.0% |
| Q1 2020 | $173,000 | +11.6% | 33,815 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $155,000 | +70.3% | 33,815 | +128.2% | 0.00% | – |
| Q3 2019 | $91,000 | +1.1% | 14,815 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $90,000 | -37.9% | 14,815 | +6.7% | 0.00% | 0.0% |
| Q3 2018 | $145,000 | – | 13,882 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,006,667 | $16,053,000 | 2.62% |
| ARS Investment Partners, LLC | 860,002 | $6,880,000 | 0.84% |
| Gagnon Advisors, LLC | 129,573 | $1,037,000 | 0.77% |
| GAGNON SECURITIES LLC | 201,698 | $1,614,000 | 0.58% |
| PERKINS CAPITAL MANAGEMENT INC | 74,500 | $596,000 | 0.54% |
| Benchmark Capital Advisors | 75,092 | $601,000 | 0.48% |
| Cortina Asset Management, LLC | 524,388 | $4,195,000 | 0.21% |
| Whitegate Investment Counselors, Inc. | 11,000 | $88,000 | 0.02% |
| Phocas Financial Corp. | 20,000 | $160,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 215,353 | $1,723,000 | 0.01% |